Programmed Death Receptor-1 Blocking Antibody [EPC]

18 drugs in this class with 922,329 total adverse event reports.

18 Drugs

922,329 Total Reports

520,938 Serious Reports

173,553 Death Reports

#	Drug Name	Generic Name	Reports	Serious	Deaths
1	Carboplatin	CARBOPLATIN	122,602	66,132	19,569
2	Bevacizumab	BEVACIZUMAB	120,853	52,978	27,863
3	Pembrolizumab	PEMBROLIZUMAB	100,428	73,843	18,175
4	Paclitaxel	PACLITAXEL	95,861	50,663	15,996
5	Nivolumab	NIVOLUMAB	94,349	55,197	24,314
6	Paclitaxel (Aibumin-Bound)	PACLITAXEL (AIBUMIN-BOUND)	79,282	43,516	11,097
7	Cabozantinib	CABOZANTINIB	46,986	32,516	5,140
8	Ipilimumab	IPILIMUMAB	42,014	22,225	9,368
9	Atezolizumab	ATEZOLIZUMAB	37,421	22,926	9,568
10	Pemetrexed Disodium	PEMETREXED DISODIUM	36,708	20,401	7,045
11	Lenvatinib	LENVATINIB	31,670	20,924	4,321
12	Trametinib	TRAMETINIB	23,697	12,388	5,097
13	Dabrafenib	DABRAFENIB	20,691	10,115	4,365
14	Pemetrexed	PEMETREXED	20,371	13,801	3,627
15	Axitinib	AXITINIB	19,195	10,700	3,860
16	Vemurafenib	VEMURAFENIB	11,910	3,312	2,066
17	Encorafenib	ENCORAFENIB	9,531	6,524	1,580
18	Rucaparib	RUCAPARIB	8,760	2,777	502